Arvinas, Inc. SEC filings ARVN
Arvinas, Inc. has 602 filings in SEC EDGAR's recent list, going back to Oct 23, 2015. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 24, 2026 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 25, 2025 |
| DEFA14A | Additional proxy material | Apr 16, 2024 | — |
| DEF 14A | Proxy statement | Apr 16, 2024 | May 29, 2024 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | — |
| DEFA14A | Additional proxy material | Apr 27, 2022 | — |
| DEF 14A | Proxy statement | Apr 27, 2022 | Jun 16, 2022 |
| DEFA14A | Additional proxy material | Apr 26, 2021 | — |
| DEF 14A | Proxy statement | Apr 26, 2021 | Jun 8, 2021 |
| DEFA14A | Additional proxy material | May 20, 2020 | — |
| DEFA14A | Additional proxy material | Apr 21, 2020 | — |
| DEF 14A | Proxy statement | Apr 21, 2020 | Jun 3, 2020 |
| DEFA14A | Additional proxy material | Apr 12, 2019 | — |
| DEF 14A | Proxy statement | Apr 12, 2019 | May 23, 2019 |
Showing 17 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- ARVN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New Haven, CT
- SEC filer status
- Accelerated filer
- SEC CIK
- 1655759
- Former names
- ARVINAS INC. (until Oct 10, 2018); ARVINAS HOLDING COMPANY, LLC (until Sep 28, 2018)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.